Pfizer Consumer Healthcare

Ver el organigrama con sus 4 ejecutivos principales

Biografías más buscadas en Pfizer Consumer Healthcare

• Frank Outslay, Vice President, Finance
• Tony Dimiceli, Vice President, Global Marketing Insights
• Kevin Colgan, Head, Global Communications

Crear su alerta
para seguir los movimientos de los ejecutivos en Pfizer Consumer Healthcare.

Pfizer Consumer Healthcare tiene 1.867 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).

Popular M&A news in Farmacia

• AstraZeneca has announced the acquisition of Fusion Pharma  (publicado el 23 de marzo de 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (publicado el 19 de marzo de 2024).
• Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).

Otros contactos sugeridos en el sector Farmacia

• Jean-Frédéric Paulsen - Executive Chairman of the Board en Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director en Dirk Rossmann
• Thierry Abribat - Chief Executive Officer en Amolyt Pharma

Saber más sobre el sector Farmacia >

Últimos comunicados de prensa de Pfizer Consumer Healthcare

• Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral Antiviral Treatment Candidate in Reducing Risk of Hospitalization or Death | Pfizer
• PFIZER AND SANGAMO ANNOUNCE UPDATED PHASE 1/2 RESULTS SHOWING SUSTAINED BLEEDING CONTROL IN HIGHEST DOSE COHORT THROUGH TWO YEARS FOLLOWING HEMOPHILIA A GENE THERAPY | Pfizer
• Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older | Pfizer
• Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis | Pfizer
• Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States | Pfizer
• FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine in Children 5 to
• Myovant Sciences and Pfizer Present Data on Relugolix Combination Therapy from Studies in Uterine Fibroids and Endometriosis at the American Society for Reproductive Medicine Congress | Pfizer
• Japan’s MHLW Approves Pfizer’s CIBINQO® (abrocitinib) for Adults and Adolescents with Moderate to Severe Atopic Dermatitis | Pfizer
• Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to
• Valneva and Pfizer Report Further Positive Phase 2 Results, Including Booster Response, for Lyme Disease Vaccine Candidate | Pfizer
• View more press releases Close

Redes sociales sobre Pfizer Consumer Healthcare

• Pfizer Consumer Healthcare en Wikipedia, Google News y Yahoo Finance
• Pfizer Consumer Healthcare en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Kevin Colgan

Llame a Pfizer Consumer Healthcare al +1 212...

Ver el organigrama

Register to receive your alert

Señalar un error